Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Equasym
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Equasym XL 30mg capsules
0404000M0BCAFAV
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | 26,785 |
|
Equasym XL 20mg capsules
0404000M0BCAEAQ
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | 23,301 |
|
Equasym XL 10mg capsules
0404000M0BCADAU
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | 13,078 |
|
Equasym 10mg tablets
0404000M0BCABAA
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 20mg tablets
0404000M0BCACAK
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 5mg tablets
0404000M0BCAAAJ
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.